Wikidata

(Q63399259)

English

Effect of Benralizumab in Atopic Dermatitis

clinical trial

In more languages

Statements

title
Benralizumab Regulates Atopic Dermatitis Through Effects on Eosinophils, Basophils and Innate Lymphoid Type 2 Cells. (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
hypersensitivity
0 references
country
Canada
0 references
start time
4 September 2018
0 references
end time
July 2019
0 references
number of participants
20
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63399259&oldid=1857209031"